Underwood M A, Bartlett J M, Cooke T G
University Department of Surgery, Glasgow Royal Infirmary, Scotland.
PCR Methods Appl. 1994 Dec;4(3):178-84. doi: 10.1101/gr.4.3.178.
A differential PCR-based assay is presented that increases the accuracy of quantification of C-erbB-2 gene-copy number in DNA extracted from archival tumors. The C-erbB-2 gene is amplified in a high percentage of human adenocarcinomas arising at numerous sites, including breast, lung, and stomach. A number of studies have correlated C-erbB-2 with poor prognosis. Gene copy number may be relevant in identifying patients with different clinical outcomes. In this study a target gene and a single copy reference gene were coamplified in the same reaction tube. The level of target gene amplification was reflected by the ratio of the two resulting PCR products. Cell lines exhibiting variable copies ranging from 1 to > 8 of the C-erbB-2 gene were used as quality controls. This technique can reliably show a single copy difference between cell lines and can be used to semiquantitatively estimate gene copy number in DNA extracted from archival paraffin-embedded samples.
本文介绍了一种基于差异PCR的检测方法,该方法提高了从存档肿瘤中提取的DNA中C-erbB-2基因拷贝数定量的准确性。C-erbB-2基因在包括乳腺、肺和胃等多个部位发生的高比例人类腺癌中扩增。许多研究已将C-erbB-2与不良预后相关联。基因拷贝数可能与识别具有不同临床结果的患者有关。在本研究中,靶基因和单拷贝参考基因在同一反应管中共同扩增。靶基因扩增水平由两个PCR产物的比例反映。使用显示C-erbB-2基因拷贝数从1到>8不等的细胞系作为质量控制。该技术可以可靠地显示细胞系之间的单拷贝差异,并可用于半定量估计从存档石蜡包埋样本中提取的DNA中的基因拷贝数。